Do not use Ultomiris:
- If you are allergic to the active ingredient (ravulizumab) or any of the other ingredients of this medicine (sodium phosphate dibasic heptahydrate, sodium phosphate monobasic monohydrate, sodium chloride, polysorbate 80, water for injections)1
- If you have not been vaccinated against meningococcal infection or if you are not using antibiotics to reduce the risk of infection until 2 weeks after you have been vaccinated1
- If you have meningococcal infection1
- If you are using, have recently used, or plan to use any other medicines1
- If you have any infections1
- Ultomiris®. Patient Information Leaflet. European Medicines Agency. https://www.ema.europa.eu/en/documents/product-information/ultomiris-epar-product-information_en.pdf
POSSIBLE SIDE EFFECTS
Like all medicines, Ultomiris can cause side effects, although not everybody gets them. Your doctor will discuss the possible side effects with you and explain the risks and...
TREATMENT FOR MENINGOCOCCAL INFECTION WHILE TRAVELLING
If you are travelling in a region where you are unable to contact your doctor or will be temporarily unable to...
WHAT SHOULD ALERT ME
Should you experience any signs of meningococcal infection despite being vaccinated, it’s crucial to immediately identify the symptoms and start antibiotic treatment without delay...
The information on this website is provided by Alexion, AstraZeneca Rare Disease for educational purposes only and is for people prescribed an Alexion medicine. It is not intended nor implied to be a substitute for professional medical advice. If you have any questions about your medical condition, please talk to your doctor or other health care provider.
To report any safety information concerning our products please contact us.
To report any safety information concerning our products please contact us.